{"id":"W3110108782","doi":"10.1016/j.jaad.2020.06.677","title":"15328 Efficacy and safety of mirikizumab in patients with moderate to severe plaque psoriasis: 104-week results from a randomized phase 2 study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis Area and Severity Index; Plaque psoriasis; Psoriasis; Placebo; Internal medicine; Dermatology; Randomized controlled trial; Gastroenterology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001569667,0.001520308,0.003688662,0.0004330105,0.0004719075,0.0008793866,0.0008630645,0.001816629,0.005159623],"category_scores_gemma":[0.001332934,0.0009205539,0.001851089,0.0003883261,0.001005446,0.0009985218,0.0003284324,0.002887672,0.001133446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00055553,"about_ca_system_score_gemma":0.0007715608,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005212447,"about_ca_topic_score_gemma":0.001044634,"domain_scores_codex":[0.9992341,0.0003969132,0.00004658397,0.0001156788,0.00007897011,0.000127837],"domain_scores_gemma":[0.9992954,0.0002125103,0.0001511587,0.0000694688,0.00004716138,0.0002242654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9239507,0.0176531,0.0014082,0.0005940094,0.00112433,0.00009259008,0.00007574003,0.000515918,0.01776927,0.000102795,0.001224919,0.03548843],"study_design_scores_gemma":[0.8708608,0.1210863,0.005580286,0.00001866322,0.0004437494,0.00006423645,0.00001980696,0.0003865315,0.0008270071,0.00008027053,0.0006073998,0.00002502123],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929579,0.002911114,0.0005311938,0.0003614326,0.0001654261,0.001225347,0.0004714458,0.000137651,0.001238339],"genre_scores_gemma":[0.9900745,0.001781474,0.001652204,0.0009186153,0.0003248047,0.001919655,0.000913617,0.00005555932,0.0023597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005159623,"threshold_uncertainty_score":0.01726061,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01574543642778634,"score_gpt":0.2625358340282847,"score_spread":0.2467903976004983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}